Molecular Qubit Achieves Single-Photon Quantum Control

Forbes profiled NVision’s $55 million Series B financing round, led by Abbott, and the company’s efforts to scale its quantum-enhanced metabolic imaging platform. The article highlights how POLARIS boosts MRI signals by more than 10,000 times, enabling researchers to visualize tumor metabolism and assess treatment response within days rather than months. It also outlines NVision’s plans to expand to 20 research centers worldwide and apply its molecular quantum technology to drug discovery and development.

Read the full article on Forbes.com ↗

‍

Science profiled NVision’s development of molecular spin qubits, highlighting the first optical control of quantum information in a single organic molecule. The article explains how designer molecules could offer long coherence times, bright optical signals, and a scalable path to photonic chip integration.

Read the full article on Science.org